CIK 0001956827 · Accelerated filer<br>Emerging growth company
Abivax S.A.
Sign in to watch- Ticker
- AAVXF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- France
- Entity type
- other
- Phone
- 01 53 83 09 63
- Business address
- 7 BD HAUSSMANN, PARIS, France
Securities
- ABVX American Depositary Shares Nasdaq
- AAVXF Common stock OTC
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SC 13G Stake Amended Statement of Ownership
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- 6-K Event Report of Foreign Issuer
- SC 13G/A Stake Amended Statement of Ownership
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 424B4 Offering Prospectus
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
Page 4 of 6 · 105 filings